Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from GENinCode UK Ltd. ( (GB:GENI) ).
GENinCode UK Ltd has announced plans to raise a minimum of £4.0 million through a placing and subscription, with an additional retail offer aiming to raise up to £0.5 million. The funds will be used to complete the company’s US regulatory and reimbursement program and to expand its commercial activities in the US, UK, and Europe. The initiative is expected to position GENinCode on a pathway to profitability over the medium term, with the fundraising being contingent upon shareholder approval at the upcoming general meeting.
More about GENinCode UK Ltd.
GENinCode UK Ltd is a genetics company focused on the prevention of cardiovascular disease and the early detection of ovarian cancer. The company operates in the biotechnology industry, concentrating on genetic testing and diagnostics to improve health outcomes, particularly in the cardiovascular and oncology sectors.
YTD Price Performance: 2.63%
Average Trading Volume: 602,504
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £6.9M
See more insights into GENI stock on TipRanks’ Stock Analysis page.
